JCR Pharmaceuticals Co., Ltd. (4552.T)
JPY 610.0
(-0.81%)
JPY 610.0
(-0.81%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 102.22 Billion JPY | 7.68% |
| 2022 | 94.93 Billion JPY | -2.26% |
| 2021 | 97.13 Billion JPY | 31.65% |
| 2020 | 73.78 Billion JPY | 54.44% |
| 2019 | 47.77 Billion JPY | 12.37% |
| 2018 | 42.51 Billion JPY | 10.72% |
| 2017 | 38.39 Billion JPY | 5.53% |
| 2016 | 36.38 Billion JPY | 2.94% |
| 2015 | 35.34 Billion JPY | 3.7% |
| 2014 | 34.08 Billion JPY | 1.86% |
| 2013 | 33.46 Billion JPY | 6.96% |
| 2012 | 31.28 Billion JPY | 8.01% |
| 2011 | 28.96 Billion JPY | -2.85% |
| 2010 | 29.81 Billion JPY | 2.3% |
| 2009 | 29.14 Billion JPY | 17.69% |
| 2008 | 24.76 Billion JPY | 2.26% |
| 2007 | 24.21 Billion JPY | -0.75% |
| 2006 | 24.4 Billion JPY | 17.33% |
| 2005 | 20.79 Billion JPY | -4.59% |
| 2004 | 21.79 Billion JPY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 104.16 Billion JPY | 0.88% |
| 2024 Q2 | 104.62 Billion JPY | 8.58% |
| 2023 Q1 | 95.77 Billion JPY | 0.88% |
| 2023 Q3 | 102.77 Billion JPY | -1.17% |
| 2023 Q2 | 103.98 Billion JPY | 8.58% |
| 2023 Q4 | 102.22 Billion JPY | -0.53% |
| 2023 FY | 102.22 Billion JPY | 7.68% |
| 2022 Q2 | 89.38 Billion JPY | -3.36% |
| 2022 Q4 | 94.93 Billion JPY | 3.5% |
| 2022 FY | 94.93 Billion JPY | -2.26% |
| 2022 Q1 | 92.49 Billion JPY | -4.77% |
| 2022 Q3 | 91.72 Billion JPY | 2.62% |
| 2021 Q3 | 93.43 Billion JPY | 7.86% |
| 2021 Q4 | 97.13 Billion JPY | 3.96% |
| 2021 FY | 97.13 Billion JPY | 31.65% |
| 2021 Q1 | 76.26 Billion JPY | 3.36% |
| 2021 Q2 | 86.61 Billion JPY | 13.58% |
| 2020 Q1 | 56.39 Billion JPY | 18.05% |
| 2020 Q4 | 73.78 Billion JPY | 10.94% |
| 2020 FY | 73.78 Billion JPY | 54.44% |
| 2020 Q2 | 59.7 Billion JPY | 5.87% |
| 2020 Q3 | 66.51 Billion JPY | 11.39% |
| 2019 Q1 | 41.65 Billion JPY | -2.02% |
| 2019 FY | 47.77 Billion JPY | 12.37% |
| 2019 Q3 | 45.69 Billion JPY | 0.15% |
| 2019 Q4 | 47.77 Billion JPY | 4.56% |
| 2019 Q2 | 45.62 Billion JPY | 9.53% |
| 2018 Q1 | 37.81 Billion JPY | -1.53% |
| 2018 FY | 42.51 Billion JPY | 10.72% |
| 2018 Q4 | 42.51 Billion JPY | 7.57% |
| 2018 Q3 | 39.52 Billion JPY | 0.55% |
| 2018 Q2 | 39.3 Billion JPY | 3.95% |
| 2017 Q1 | 37.35 Billion JPY | 2.67% |
| 2017 FY | 38.39 Billion JPY | 5.53% |
| 2017 Q2 | 38.2 Billion JPY | 2.28% |
| 2017 Q4 | 38.39 Billion JPY | -2.94% |
| 2017 Q3 | 39.56 Billion JPY | 3.54% |
| 2016 Q4 | 36.38 Billion JPY | 0.28% |
| 2016 FY | 36.38 Billion JPY | 2.94% |
| 2016 Q3 | 36.28 Billion JPY | -1.15% |
| 2016 Q2 | 36.7 Billion JPY | 0.77% |
| 2016 Q1 | 36.42 Billion JPY | 3.04% |
| 2015 Q3 | 35.91 Billion JPY | 0.78% |
| 2015 Q2 | 35.63 Billion JPY | 2.85% |
| 2015 Q1 | 34.64 Billion JPY | 1.64% |
| 2015 Q4 | 35.34 Billion JPY | -1.58% |
| 2015 FY | 35.34 Billion JPY | 3.7% |
| 2014 FY | 34.08 Billion JPY | 1.86% |
| 2014 Q4 | 34.08 Billion JPY | 1.6% |
| 2014 Q3 | 33.54 Billion JPY | -3.14% |
| 2014 Q2 | 34.63 Billion JPY | 2.53% |
| 2014 Q1 | 33.78 Billion JPY | 0.95% |
| 2013 FY | 33.46 Billion JPY | 6.96% |
| 2013 Q1 | 31.99 Billion JPY | 2.25% |
| 2013 Q2 | 32.14 Billion JPY | 0.48% |
| 2013 Q3 | 31.89 Billion JPY | -0.78% |
| 2013 Q4 | 33.46 Billion JPY | 4.92% |
| 2012 Q2 | 30.58 Billion JPY | 5.31% |
| 2012 Q4 | 31.28 Billion JPY | 2.2% |
| 2012 FY | 31.28 Billion JPY | 8.01% |
| 2012 Q1 | 29.03 Billion JPY | 0.25% |
| 2012 Q3 | 30.61 Billion JPY | 0.1% |
| 2011 FY | 28.96 Billion JPY | -2.85% |
| 2011 Q4 | 28.96 Billion JPY | -1.77% |
| 2011 Q3 | 29.48 Billion JPY | -1.86% |
| 2011 Q2 | 30.04 Billion JPY | -2.1% |
| 2011 Q1 | 30.69 Billion JPY | 2.94% |
| 2010 Q3 | 29.9 Billion JPY | 0.07% |
| 2010 Q4 | 29.81 Billion JPY | -0.28% |
| 2010 FY | 29.81 Billion JPY | 2.3% |
| 2010 Q1 | 30.14 Billion JPY | 3.4% |
| 2010 Q2 | 29.88 Billion JPY | -0.86% |
| 2009 FY | 29.14 Billion JPY | 17.69% |
| 2009 Q2 | 24.35 Billion JPY | 0.0% |
| 2009 Q4 | 29.14 Billion JPY | 14.56% |
| 2009 Q3 | 25.44 Billion JPY | 4.45% |
| 2008 Q3 | 24.37 Billion JPY | 0.0% |
| 2008 Q4 | 24.76 Billion JPY | 1.6% |
| 2008 FY | 24.76 Billion JPY | 2.26% |
| 2007 FY | 24.21 Billion JPY | -0.75% |
| 2006 FY | 24.4 Billion JPY | 17.33% |
| 2005 FY | 20.79 Billion JPY | -4.59% |
| 2004 FY | 21.79 Billion JPY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Kyowa Kirin Co., Ltd. | 1025.94 Billion JPY | 90.036% |
| Astellas Pharma Inc. | 3569.6 Billion JPY | 97.136% |
| Chugai Pharmaceutical Co., Ltd. | 1932.54 Billion JPY | 94.71% |
| Ono Pharmaceutical Co., Ltd. | 913.66 Billion JPY | 88.811% |
| Santen Pharmaceutical Co., Ltd. | 435.69 Billion JPY | 76.537% |
| Daiichi Sankyo Company, Limited | 3461.13 Billion JPY | 97.046% |
| Otsuka Holdings Co., Ltd. | 3361.24 Billion JPY | 96.959% |
| Perseus Proteomics Inc. | 1.69 Billion JPY | -5935.27% |